Prior notification of a concentration (Case M.9845 – Davidson Kempner Capital Management/GoldenTree Asset Management/Quorum Health Corporation) Candidate case for simplified procedure (Text with EEA relevance) 2020/C 160/05
Date: 2020-05-11
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, health service, investment company, merger control








C_2020160EN.01001501.xml










11.5.2020   


EN


Official Journal of the European Union


C 160/15






Prior notification of a concentration
(Case M.9845 – Davidson Kempner Capital Management/GoldenTree Asset Management/Quorum Health Corporation)
Candidate case for simplified procedure
(Text with EEA relevance)
(2020/C 160/05)

1.   
On 30 April 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


Davidson Kempner Capital Management LP (‘Davidson Kempner’, United States),










—


GoldenTree Asset Management LP (‘GoldenTree’, United States),










—


Quorum Health Corporation (‘Quorum Health Corporation’, United States).




Davidson Kempner and GoldenTree acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Quorum Health Corporation.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are:






—


for Davidson Kempner: alternative asset manager based and mainly active in the United States, pursuing a variety of investment strategies, including a number of investments in distressed debt, high yield bonds, leveraged loans, structured products, aircraft and shipping, and real property,










—


for GoldenTree: asset manager based in the United States and active globally, specialising in credit-based opportunities via high yield bonds, leveraged loans, distressed debt, structured products, emerging markets, private equity and credit-themed equities,










—


for Quorum Health Corporation: provision of hospital services in the United States.






3.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.9845 – Davidson Kempner Capital Management/GoldenTree Asset Management/Quorum Health Corporation
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.